Structure

Physi-Chem Properties

Molecular Weight:  286.23
Volume:  329.688
LogP:  6.146
LogD:  4.737
LogS:  -6.047
# Rotatable Bonds:  1
TPSA:  20.23
# H-Bond Aceptor:  1
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.718
Synthetic Accessibility Score:  3.389
Fsp3:  0.7
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.015
MDCK Permeability:  1.1975819688814227e-05
Pgp-inhibitor:  0.798
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.027
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.223
Plasma Protein Binding (PPB):  98.25569152832031%
Volume Distribution (VD):  3.034
Pgp-substrate:  2.186680555343628%

ADMET: Metabolism

CYP1A2-inhibitor:  0.263
CYP1A2-substrate:  0.87
CYP2C19-inhibitor:  0.466
CYP2C19-substrate:  0.922
CYP2C9-inhibitor:  0.244
CYP2C9-substrate:  0.906
CYP2D6-inhibitor:  0.707
CYP2D6-substrate:  0.893
CYP3A4-inhibitor:  0.494
CYP3A4-substrate:  0.548

ADMET: Excretion

Clearance (CL):  9.002
Half-life (T1/2):  0.079

ADMET: Toxicity

hERG Blockers:  0.043
Human Hepatotoxicity (H-HT):  0.078
Drug-inuced Liver Injury (DILI):  0.116
AMES Toxicity:  0.029
Rat Oral Acute Toxicity:  0.419
Maximum Recommended Daily Dose:  0.925
Skin Sensitization:  0.863
Carcinogencity:  0.1
Eye Corrosion:  0.063
Eye Irritation:  0.928
Respiratory Toxicity:  0.926

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC176279

Natural Product ID:  NPC176279
Common Name*:   Sempervirol
IUPAC Name:   (4bS,8aS)-4b,8,8-trimethyl-3-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-ol
Synonyms:   Sempervirol
Standard InCHIKey:  RSIJAQZNHHXEJZ-AZUAARDMSA-N
Standard InCHI:  InChI=1S/C20H30O/c1-13(2)15-12-16-14(11-17(15)21)7-8-18-19(3,4)9-6-10-20(16,18)5/h11-13,18,21H,6-10H2,1-5H3/t18-,20+/m0/s1
SMILES:  CC(c1cc2c(cc1O)CC[C@@H]1[C@]2(C)CCCC1(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1097038
PubChem CID:   12442761
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota feces n.a. n.a. PMID[20402524]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8300 Apis mellifera ligustica Species Apidae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 40000.0 nM PMID[466537]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 40000.0 nM PMID[466537]
NPT15 Cell Line Jurkat Homo sapiens IC50 > 40000.0 nM PMID[466537]
NPT466 Cell Line U-937 Homo sapiens IC50 > 40000.0 nM PMID[466537]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC176279 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC260323
0.9717 High Similarity NPC195922
0.9714 High Similarity NPC250323
0.9712 High Similarity NPC141782
0.9626 High Similarity NPC192948
0.9626 High Similarity NPC35797
0.9612 High Similarity NPC151477
0.9537 High Similarity NPC477137
0.9537 High Similarity NPC471668
0.9537 High Similarity NPC38893
0.9537 High Similarity NPC308311
0.9524 High Similarity NPC13482
0.945 High Similarity NPC172219
0.945 High Similarity NPC304510
0.9439 High Similarity NPC715
0.9417 High Similarity NPC117115
0.9364 High Similarity NPC471671
0.9358 High Similarity NPC219112
0.9352 High Similarity NPC268160
0.9346 High Similarity NPC46940
0.9327 High Similarity NPC21594
0.9279 High Similarity NPC93071
0.9279 High Similarity NPC126002
0.9279 High Similarity NPC469644
0.9273 High Similarity NPC477136
0.9266 High Similarity NPC147179
0.9252 High Similarity NPC322753
0.9252 High Similarity NPC95716
0.9245 High Similarity NPC58865
0.9182 High Similarity NPC308828
0.9182 High Similarity NPC469663
0.9182 High Similarity NPC92
0.9151 High Similarity NPC11554
0.9099 High Similarity NPC16030
0.9091 High Similarity NPC469719
0.9074 High Similarity NPC77772
0.9074 High Similarity NPC151537
0.9065 High Similarity NPC314187
0.9035 High Similarity NPC249340
0.9035 High Similarity NPC162935
0.9029 High Similarity NPC211885
0.9018 High Similarity NPC469609
0.9018 High Similarity NPC154030
0.8981 High Similarity NPC132720
0.8962 High Similarity NPC271274
0.8957 High Similarity NPC11250
0.8947 High Similarity NPC32322
0.8947 High Similarity NPC259703
0.8909 High Similarity NPC317869
0.8909 High Similarity NPC322239
0.8899 High Similarity NPC266937
0.8899 High Similarity NPC470770
0.8879 High Similarity NPC471187
0.887 High Similarity NPC154696
0.886 High Similarity NPC135467
0.886 High Similarity NPC260832
0.885 High Similarity NPC206
0.8846 High Similarity NPC225506
0.8839 High Similarity NPC141001
0.8829 High Similarity NPC471534
0.8818 High Similarity NPC62867
0.8818 High Similarity NPC471179
0.8818 High Similarity NPC177962
0.8818 High Similarity NPC228425
0.8803 High Similarity NPC181334
0.8793 High Similarity NPC176208
0.8783 High Similarity NPC241001
0.8774 High Similarity NPC238696
0.8762 High Similarity NPC252105
0.8761 High Similarity NPC299180
0.875 High Similarity NPC252821
0.875 High Similarity NPC122005
0.875 High Similarity NPC299762
0.875 High Similarity NPC33675
0.8729 High Similarity NPC137750
0.8707 High Similarity NPC253627
0.8704 High Similarity NPC320439
0.8684 High Similarity NPC164649
0.8684 High Similarity NPC48342
0.8655 High Similarity NPC325294
0.8655 High Similarity NPC321822
0.8655 High Similarity NPC100414
0.8655 High Similarity NPC43000
0.8654 High Similarity NPC77492
0.8654 High Similarity NPC79241
0.8654 High Similarity NPC6597
0.8641 High Similarity NPC144682
0.8641 High Similarity NPC222146
0.8636 High Similarity NPC296683
0.8632 High Similarity NPC121168
0.8632 High Similarity NPC297057
0.8632 High Similarity NPC471794
0.8621 High Similarity NPC328504
0.8609 High Similarity NPC151197
0.8609 High Similarity NPC42657
0.8598 High Similarity NPC272029
0.8585 High Similarity NPC51015
0.8584 High Similarity NPC246760
0.8584 High Similarity NPC84999
0.8583 High Similarity NPC176130
0.8583 High Similarity NPC78364
0.8583 High Similarity NPC108164
0.8583 High Similarity NPC471077
0.8583 High Similarity NPC69424
0.8583 High Similarity NPC84672
0.8571 High Similarity NPC321589
0.8571 High Similarity NPC124030
0.8571 High Similarity NPC263753
0.8559 High Similarity NPC198014
0.8559 High Similarity NPC469912
0.8558 High Similarity NPC312132
0.8558 High Similarity NPC259512
0.8534 High Similarity NPC190501
0.8534 High Similarity NPC478121
0.8534 High Similarity NPC99734
0.8534 High Similarity NPC318552
0.8519 High Similarity NPC99557
0.8519 High Similarity NPC47284
0.8519 High Similarity NPC219286
0.8519 High Similarity NPC243601
0.8519 High Similarity NPC138942
0.8509 High Similarity NPC247858
0.8509 High Similarity NPC474358
0.8509 High Similarity NPC257540
0.8509 High Similarity NPC474387
0.8509 High Similarity NPC137496
0.8509 High Similarity NPC312105
0.8509 High Similarity NPC154511
0.8505 High Similarity NPC168829
0.8505 High Similarity NPC269212
0.8496 Intermediate Similarity NPC107240
0.8496 Intermediate Similarity NPC249270
0.8491 Intermediate Similarity NPC72729
0.8476 Intermediate Similarity NPC225464
0.8475 Intermediate Similarity NPC478058
0.8475 Intermediate Similarity NPC71094
0.8475 Intermediate Similarity NPC152946
0.8468 Intermediate Similarity NPC224870
0.8462 Intermediate Similarity NPC8392
0.8455 Intermediate Similarity NPC64586
0.8448 Intermediate Similarity NPC176893
0.8443 Intermediate Similarity NPC276238
0.844 Intermediate Similarity NPC53740
0.843 Intermediate Similarity NPC72667
0.8426 Intermediate Similarity NPC288411
0.8417 Intermediate Similarity NPC76119
0.8417 Intermediate Similarity NPC87985
0.8417 Intermediate Similarity NPC4286
0.8407 Intermediate Similarity NPC117846
0.8396 Intermediate Similarity NPC92730
0.839 Intermediate Similarity NPC142198
0.839 Intermediate Similarity NPC77569
0.8376 Intermediate Similarity NPC103916
0.8374 Intermediate Similarity NPC108129
0.8365 Intermediate Similarity NPC27323
0.8365 Intermediate Similarity NPC245187
0.8365 Intermediate Similarity NPC316301
0.8365 Intermediate Similarity NPC152415
0.8365 Intermediate Similarity NPC289769
0.8364 Intermediate Similarity NPC27252
0.8364 Intermediate Similarity NPC472979
0.8361 Intermediate Similarity NPC201069
0.8348 Intermediate Similarity NPC261973
0.8347 Intermediate Similarity NPC254492
0.8333 Intermediate Similarity NPC224342
0.8333 Intermediate Similarity NPC199273
0.8319 Intermediate Similarity NPC302371
0.8319 Intermediate Similarity NPC321402
0.8306 Intermediate Similarity NPC471851
0.8305 Intermediate Similarity NPC129176
0.8302 Intermediate Similarity NPC32674
0.8302 Intermediate Similarity NPC156313
0.8293 Intermediate Similarity NPC303910
0.8293 Intermediate Similarity NPC171460
0.8291 Intermediate Similarity NPC323074
0.8288 Intermediate Similarity NPC64642
0.8288 Intermediate Similarity NPC472982
0.8288 Intermediate Similarity NPC149455
0.8279 Intermediate Similarity NPC186889
0.8279 Intermediate Similarity NPC476536
0.8276 Intermediate Similarity NPC25648
0.8273 Intermediate Similarity NPC155072
0.8273 Intermediate Similarity NPC54765
0.8273 Intermediate Similarity NPC310456
0.8269 Intermediate Similarity NPC55903
0.8257 Intermediate Similarity NPC475225
0.8241 Intermediate Similarity NPC477685
0.824 Intermediate Similarity NPC321086
0.8235 Intermediate Similarity NPC474115
0.823 Intermediate Similarity NPC476632
0.823 Intermediate Similarity NPC165770
0.823 Intermediate Similarity NPC4493
0.823 Intermediate Similarity NPC470723
0.823 Intermediate Similarity NPC224527
0.823 Intermediate Similarity NPC225679
0.822 Intermediate Similarity NPC318581
0.822 Intermediate Similarity NPC325544
0.822 Intermediate Similarity NPC68339
0.822 Intermediate Similarity NPC477037
0.8214 Intermediate Similarity NPC186385

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC176279 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8879 High Similarity NPD2342 Discontinued
0.8684 High Similarity NPD3091 Approved
0.8649 High Similarity NPD7635 Approved
0.8641 High Similarity NPD1809 Phase 2
0.8558 High Similarity NPD288 Approved
0.8534 High Similarity NPD4059 Approved
0.8534 High Similarity NPD3019 Approved
0.8462 Intermediate Similarity NPD844 Approved
0.8396 Intermediate Similarity NPD3020 Approved
0.839 Intermediate Similarity NPD3092 Approved
0.8376 Intermediate Similarity NPD2932 Approved
0.8365 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD845 Approved
0.822 Intermediate Similarity NPD3095 Discontinued
0.8214 Intermediate Similarity NPD4750 Phase 3
0.8148 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.8136 Intermediate Similarity NPD4093 Discontinued
0.8115 Intermediate Similarity NPD3094 Phase 2
0.8113 Intermediate Similarity NPD2859 Approved
0.8113 Intermediate Similarity NPD2860 Approved
0.8067 Intermediate Similarity NPD1751 Approved
0.8067 Intermediate Similarity NPD2286 Discontinued
0.8053 Intermediate Similarity NPD3021 Approved
0.8053 Intermediate Similarity NPD3022 Approved
0.8019 Intermediate Similarity NPD2934 Approved
0.8019 Intermediate Similarity NPD2933 Approved
0.7984 Intermediate Similarity NPD5736 Approved
0.7969 Intermediate Similarity NPD4097 Suspended
0.7951 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.792 Intermediate Similarity NPD2606 Approved
0.792 Intermediate Similarity NPD2605 Approved
0.7857 Intermediate Similarity NPD5156 Approved
0.7857 Intermediate Similarity NPD5155 Approved
0.7851 Intermediate Similarity NPD3026 Approved
0.7851 Intermediate Similarity NPD3023 Approved
0.784 Intermediate Similarity NPD3635 Approved
0.784 Intermediate Similarity NPD3637 Approved
0.784 Intermediate Similarity NPD3636 Approved
0.7833 Intermediate Similarity NPD3025 Approved
0.7833 Intermediate Similarity NPD3024 Approved
0.7778 Intermediate Similarity NPD3595 Approved
0.7778 Intermediate Similarity NPD3594 Approved
0.7769 Intermediate Similarity NPD4589 Approved
0.7769 Intermediate Similarity NPD4626 Approved
0.776 Intermediate Similarity NPD4624 Approved
0.776 Intermediate Similarity NPD2195 Approved
0.776 Intermediate Similarity NPD2194 Approved
0.7759 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7739 Intermediate Similarity NPD1792 Phase 2
0.7734 Intermediate Similarity NPD6663 Approved
0.7731 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD3620 Phase 2
0.7674 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7603 Intermediate Similarity NPD5304 Approved
0.7603 Intermediate Similarity NPD5303 Approved
0.76 Intermediate Similarity NPD6696 Suspended
0.7589 Intermediate Similarity NPD846 Approved
0.7589 Intermediate Similarity NPD940 Approved
0.7578 Intermediate Similarity NPD4625 Phase 3
0.7563 Intermediate Similarity NPD497 Approved
0.7522 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.752 Intermediate Similarity NPD5327 Phase 3
0.75 Intermediate Similarity NPD111 Approved
0.75 Intermediate Similarity NPD1201 Approved
0.748 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7479 Intermediate Similarity NPD2229 Approved
0.7479 Intermediate Similarity NPD495 Approved
0.7479 Intermediate Similarity NPD2234 Approved
0.7479 Intermediate Similarity NPD498 Approved
0.7479 Intermediate Similarity NPD2228 Approved
0.7479 Intermediate Similarity NPD496 Approved
0.7478 Intermediate Similarity NPD1444 Approved
0.7478 Intermediate Similarity NPD1445 Approved
0.7459 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD7742 Approved
0.7444 Intermediate Similarity NPD7743 Approved
0.7438 Intermediate Similarity NPD7340 Approved
0.7405 Intermediate Similarity NPD4140 Approved
0.7405 Intermediate Similarity NPD4060 Phase 1
0.7402 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7398 Intermediate Similarity NPD5691 Approved
0.7385 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4749 Approved
0.736 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD5735 Approved
0.7345 Intermediate Similarity NPD1242 Phase 1
0.7333 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4725 Approved
0.7333 Intermediate Similarity NPD4721 Approved
0.7333 Intermediate Similarity NPD1398 Phase 1
0.7333 Intermediate Similarity NPD4726 Approved
0.7323 Intermediate Similarity NPD1283 Approved
0.7317 Intermediate Similarity NPD7330 Discontinued
0.7313 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7003 Approved
0.7293 Intermediate Similarity NPD6353 Approved
0.7266 Intermediate Similarity NPD1470 Approved
0.7259 Intermediate Similarity NPD5404 Approved
0.7259 Intermediate Similarity NPD5406 Approved
0.7259 Intermediate Similarity NPD5405 Approved
0.7259 Intermediate Similarity NPD5408 Approved
0.7258 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD1651 Approved
0.7252 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD3638 Discontinued
0.7217 Intermediate Similarity NPD9500 Approved
0.7213 Intermediate Similarity NPD6671 Approved
0.7185 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7154 Intermediate Similarity NPD2861 Phase 2
0.7143 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7390 Discontinued
0.7143 Intermediate Similarity NPD3143 Discontinued
0.7132 Intermediate Similarity NPD6099 Approved
0.7132 Intermediate Similarity NPD6100 Approved
0.7131 Intermediate Similarity NPD1791 Approved
0.7131 Intermediate Similarity NPD5951 Approved
0.7131 Intermediate Similarity NPD1793 Approved
0.7122 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD4908 Phase 1
0.7092 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD1281 Approved
0.7068 Intermediate Similarity NPD8032 Phase 2
0.705 Intermediate Similarity NPD8166 Discontinued
0.7049 Intermediate Similarity NPD5283 Phase 1
0.7043 Intermediate Similarity NPD3028 Approved
0.7031 Intermediate Similarity NPD2230 Approved
0.7031 Intermediate Similarity NPD3070 Discontinued
0.7031 Intermediate Similarity NPD2233 Approved
0.7031 Intermediate Similarity NPD2232 Approved
0.7021 Intermediate Similarity NPD7041 Phase 2
0.7021 Intermediate Similarity NPD2420 Approved
0.7021 Intermediate Similarity NPD2421 Approved
0.7021 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7636 Approved
0.7015 Intermediate Similarity NPD3109 Approved
0.7015 Intermediate Similarity NPD3110 Approved
0.6992 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6978 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6978 Remote Similarity NPD2209 Approved
0.6978 Remote Similarity NPD2211 Approved
0.6977 Remote Similarity NPD1669 Approved
0.6972 Remote Similarity NPD3645 Discontinued
0.6972 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6963 Remote Similarity NPD3657 Discovery
0.6953 Remote Similarity NPD1611 Approved
0.6953 Remote Similarity NPD1610 Phase 2
0.6947 Remote Similarity NPD6584 Phase 3
0.6935 Remote Similarity NPD709 Approved
0.6929 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6917 Remote Similarity NPD7095 Approved
0.6912 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6906 Remote Similarity NPD7037 Approved
0.6906 Remote Similarity NPD4257 Approved
0.6906 Remote Similarity NPD4256 Phase 2
0.6894 Remote Similarity NPD4208 Discontinued
0.6885 Remote Similarity NPD228 Approved
0.688 Remote Similarity NPD405 Clinical (unspecified phase)
0.6875 Remote Similarity NPD1980 Approved
0.6875 Remote Similarity NPD1981 Approved
0.6875 Remote Similarity NPD1983 Approved
0.6866 Remote Similarity NPD2028 Clinical (unspecified phase)
0.6864 Remote Similarity NPD9608 Approved
0.6864 Remote Similarity NPD9610 Approved
0.686 Remote Similarity NPD5451 Approved
0.6857 Remote Similarity NPD6674 Discontinued
0.6855 Remote Similarity NPD1476 Clinical (unspecified phase)
0.6809 Remote Similarity NPD6398 Clinical (unspecified phase)
0.68 Remote Similarity NPD7157 Approved
0.6797 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6797 Remote Similarity NPD2668 Approved
0.6797 Remote Similarity NPD2667 Approved
0.6794 Remote Similarity NPD8651 Approved
0.6788 Remote Similarity NPD2157 Approved
0.6772 Remote Similarity NPD7741 Discontinued
0.6767 Remote Similarity NPD4212 Discontinued
0.6765 Remote Similarity NPD6346 Approved
0.6765 Remote Similarity NPD2979 Phase 3
0.6761 Remote Similarity NPD8131 Suspended
0.6742 Remote Similarity NPD1164 Approved
0.6741 Remote Similarity NPD7294 Phase 1
0.6718 Remote Similarity NPD4659 Approved
0.6718 Remote Similarity NPD1755 Approved
0.6718 Remote Similarity NPD6582 Phase 2
0.6718 Remote Similarity NPD6583 Phase 3
0.6716 Remote Similarity NPD4207 Discontinued
0.6714 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6694 Remote Similarity NPD9377 Approved
0.6694 Remote Similarity NPD5535 Approved
0.6694 Remote Similarity NPD9379 Approved
0.6693 Remote Similarity NPD7644 Approved
0.6691 Remote Similarity NPD4108 Discontinued
0.669 Remote Similarity NPD6090 Discontinued
0.669 Remote Similarity NPD6273 Approved
0.6667 Remote Similarity NPD7458 Discontinued
0.6667 Remote Similarity NPD6387 Discontinued
0.6667 Remote Similarity NPD4198 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data